| AD | Alzheimer’s disease |
| AChEI | Acetylcholinesterase inhibitors |
| APP | Amyloid precursor protein |
| ApoE | Apolipoprotein E gene |
| ARIA | Amyloid-related imaging abnormalities |
| Aβ | β-amyloid |
| AβOs | Aβ oligomers |
| ALS | Amyotrophic lateral sclerosis |
| BBB | Blood–brain barrier |
| BuChE | Butyrylcholinesterase |
| BiP | Binding immunoglobulin protein |
| CNS | Central nervous system |
| CDK5 | Cyclin-dependent kinase 5 |
| DA | Dopamine |
| ER | Endoplasmic reticulum |
| EPR | Emopamil binding protein |
| GI | Gastrointestinal |
| GPCRs | G protein-coupled transporters |
| GRP78 | Glucose-regulated protein 78 |
| HD | Huntington’s Disease |
| IP3R | inositol 1,4,5-trisphosphate receptor |
| IRE1 | Inositol-requiring enzyme 1 |
| LDLR | Low-density lipoprotein receptor |
| LRP-1 | Low-density lipoprotein receptor-related protein 1 |
| LXRs | Liver X receptors |
| mAb | Monoclonal antibody |
| MAM | Mitochondria-associated ER membrane |
| MAC30 | Meningioma-associated protein 30 |
| MDD | Major depressive disorder |
| MS | Multiple sclerosis |
| MCI | Mild cognitive impairment |
| NFTs | Neurofibrillary tangles |
| NMDA | N-methyl-D-aspartate receptor |
| NGF | Nerve growth factor |
| PD | Parkinson’s disease |
| PET | Positron Emission Tomography |
| PGRMC1 | Progesterone receptor membrane component 1 |
| ROS | Reactive oxygen species |
| SAM | Senescence-accelerated mouse |
| TMEM97 | Transmembrane protein 97 |
| VEGF | Vascular endothelial growth factor |
| VAChT | Vesicular acetylcholine transporter |
| VLDLR | Very-low-density lipoprotein receptor |